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Site-Specific Phosphorylation of IkBa by a Novel
Ubiquitination-Dependent Protein Kinase Activity
Zhijian J. Chen,* Lana Parent,* and Tom Maniatis² Recently, it has been shown that signal-induced deg-
radation of IkBa is mediated by the ubiquitin (Ub)±*ProScript, Incorporated
proteasome pathway (Chen et al., 1995; Scherer et al.,38 Sidney Street
1995; Alkalay et al., 1995b). In this pathway, a proteinCambridge, Massachusetts 02139
targeted for degradation is first modified by covalent²Harvard University
attachment of Ub, a highly conserved polypeptide of 76Department of Molecular and Cellular Biology
amino acids (reviewed by Ciechanover, 1994). Ubiquiti-Cambridge, Massachusetts 02138
nation is a three-step process. First, Ub is activated by
a Ub-activating enzyme (E1); the activated Ub is then
transferred to a Ub carrier protein (E2, also referred to
Summary as Ub-conjugating enzyme [Ubc]); finally, Ub is conju-
gated to a protein substrate by forming an isopeptide
Signal-induced activation of the transcription factor bond between the C-terminal glycine residue of Ub and
NF-kB requires specific phosphorylation of the inhibi- the e-amino group of one or more lysine residues of the
tor IkBa and its subsequent proteolytic degradation. protein substrate. This conjugation step often requires
Phosphorylation of serine residues 32 and 36 targets a Ub protein ligase (E3). Multiple molecules of Ub can
IkBa to the ubiquitin (Ub)±proteasome pathway. Here be ligated to a protein substrate to form multi-Ub chains,
we report the identification of a large, multisubunit which are then recognized by a large ATP-dependent
kinase (molecular mass z700 kDa) that phosphory- protease (molecular mass z2000 kDa) known as the
lates IkBa at S32 and S36. Remarkably, the activity of 26S proteasome. The 26S proteasome is composed of
this kinase requires the Ub-activating enzyme (E1), a a 20S catalytic core and a 19S regulatory complex (re-
specific Ub carrier protein (E2) of the Ubc4/Ubc5 fam- viewed by Goldberg, 1995).
ily, and Ub. We also show that a ubiquitination event Multiple E2s and E3s function together to mediate
in the kinase complex is a prerequisite for specific the ubiquitination of a variety of cellular proteins. For
phosphorylation of IkBa. Thus, ubiquitination serves example, there are at least a dozen E2s in yeast that
a novel regulatory function thatdoes not involve prote- display distinct substrate specificities and carry out dis-
olysis. tinct cellular functions. The closely related E2 proteins
Ubc4 and Ubc5 are involved in the turnover of many
short-lived and abnormal proteins and play an essential
Introduction role in the stress response (Seufert and Jentsch, 1990).
Homologs of Ubc4/Ubc5 mediate the ubiquitination of
Regulation of the immune and inflammatory responses the p53 protein in conjunction with the human papilloma
requires the activation of specific sets of genes by a virus type 16 E6±E6-AP complex, which functions as an
variety of extracellular signals. These signals include E3 (Scheffner et al., 1993). These E2s have also been
mitogens (e.g., lipopolysaccharide and phorbol myris- implicated in the ubiquitination of the MATa2 repressor
tate acetate), cytokines (e.g., tumor necrosis factor a (Chen et al., 1993), cyclin B (King et al., 1995), and the
and interleukin-1b), viral proteins (e.g., the Tax protein NF-kB precursor protein p105 (Orian et al., 1995). The
of type 1 human T cell leukemia virus), antigens, phos- involvement of Ubc4/Ubc5 in the ubiquitination of such
phatase inhibitors (e.g., okadaic acid and calyculin A), diverse substrates indicates that these E2s alone cannot
and ultraviolet light. The Rel/NF-kB family of transcrip- confer substrate specificity. However, they may act to-
tional activator proteins plays an essential role in the gether with specific E3s to recognize specific sub-
signal transduction pathways that link these signals to strates. Although relatively few E3s have been identified
gene activation (reviewed by Siebenlist et al., 1994; thus far, the existence of a large family of these proteins
Thanos and Maniatis, 1995; Finco and Baldwin, 1995; is likely (Huibregtse et al., 1995).
Verma et al., 1995). NF-kB (p50/RelA[p65]) and other Ubiquitination of IkBa is regulated by signal-induced
heterodimeric Rel family proteins are sequestered in the phosphorylation at two specific residues, serine resi-
cytoplasm through their association with IkBa or IkBb, dues 32 and 36 (Chen et al., 1995). Single amino acid
members of the IkB family of inhibitor proteins. In the substitutions of one or both of these residues abolish
case of IkBa, and most likely IkBb, stimulation of cells the signal-induced phosphorylation and degradation of
leads to rapid phosphorylation and degradation of the IkBa in vivo (Brown et al., 1995; Brockman et al., 1995;
inhibitor. Consequently, NF-kB is released and translo- Traenckner et al., 1995; Whiteside et al., 1995). The same
cates into the nucleus, where it activates the expression mutations also abolish the okadaic acid±induced phos-
of target genes. Phosphorylation of IkBa per se is not phorylation and ubiquitination of IkBa in vitro (Chen et
sufficient to dissociate NF-kB from the latent complex al., 1995). Relatively little isknown about thesignal trans-
(Palombella et al., 1994; Traenckner et al., 1994; Finco duction pathways and the kinase(s) responsible for the
et al., 1994; Miyamotoet al., 1994; Lin et al.,1995; Alkalay site-specific phosphorylation of IkBa. Mutants of IkBa
et al., 1995a; DiDonato et al., 1995). Rather, phosphory- lacking S32 and S36 are resistant to induced phosphory-
lation triggers the degradation of IkBa (Brown et al., lation by a variety of stimuli, suggesting that different
1995; Brockman et al., 1995; Traenckner et al., 1995; signal transduction pathways converge on a specific
kinase or kinases. Although several kinases have beenWhiteside et al., 1995).
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implicated in the phosphorylation of IkBa, none has
been shown to phosphorylate S32 and S36 (reviewed
by Siebenlist et al., 1994; Verma et al., 1995). Thus, the
identification of a bona fide IkBa kinase has remained
elusive.
We previously reported the establishment of an in
vitro system for signal-induced phosphorylation and
ubiquitination of IkBa (Chen et al., 1995). In an effort to
identify and purify the proteins involved in these pro-
cesses, we have fractionated HeLa cell cytoplasmic ex-
tracts and assayed for specific phosphorylation and ubi-
quitination of IkBa. Here we report the identification of
a high molecular mass kinase complex that specifically
phosphorylates IkBa at S32 and S36. Surprisingly,
Ubc4/Ubc5, Ub, and E1 are not only involved in the
Figure 1. Ubiquitination of IkBa Requires Ubc4ubiquitination of IkBa, but are also required for the phos-
HeLa cell cytoplasmic extracts were separated into fraction I andphorylation of IkBa. Additional experiments reveal that
fraction II (FrI and FrII) by Mono Q chromatography. Each fractionthis IkBa kinase is activated by a prior ubiquitination
alone (lanes 3 and 7) or in combination (lane 8) was assayed for
event. Therefore, ubiquitination serves a novel regula- ubiquitination of 35S-labeled IkBa. To determine whether recombi-
tory function without involving proteolysis. nant yeast Ubc4 could substitute for fraction I in the ubiquitination
assay, we assayed Ubc4 alone (lane 2) or in combination with frac-
tion II (lane 4). As controls, a mock E. coli extract (lane 5) or recombi-
nant yeast Ubc3 (lane 6) was added together with fraction II. BothResults
Ubc4 and Ubc3 form thioesters with [125I]Ub (data not shown).
Ubc4 Is Required for the Ubiquitination
of IkBa In Vitro did not mediate the ubiquitination of IkBa in conjunction
with fraction II (Figure 1, lanes 5 and 6). RecombinantWe previously demonstrated that the phosphatase in-
hibitor okadaic acid induces the phosphorylation and human Ubc5 (Ubch5) also supported the ubiquitination
of IkBa when added together with fraction II (data notubiquitination of in vitro translated IkBa in HeLa cell
cytoplasmic extracts (Chen et al., 1995). To identify the shown). We conclude that the E2 required for ubiquitina-
tion of IkBa in HeLa cell extracts belongs to the Ubc4/enzymes involved in the in vitro ubiquitination of IkBa,
we separated the cytoplasmic extracts into two fractions Ubc5 family of E2s. Recently, another member of the
Ubc4/Ubc5 family (E2-F1) has been shown to be re-by Mono Q ion-exchange chromatography (see Experi-
mental Procedures). Fraction I is the Mono Q column quired for the degradation of IkBa in vitro (Alkalay et
al., 1995b). An important implication of our results isflowthrough, while fraction II is the 0.5 M KCl eluate.
Each fraction was assayed for its ability to support the that fraction II contains both the kinase and the E3 nec-
essary for the phosphorylation and ubiquitination ofubiquitination of IkBa. The reaction mixture contained
in vitro translated 35S-labeled IkBa, an ATP regenerating IkBa.
system, E1, Ub, Ub aldehyde (to inhibit isopeptidases),
and okadaic acid (Chen et al., 1995). A High Molecular Mass Complex Phosphorylates
IkBa at Serine Residues 32 and 36Neither fraction alone was sufficient to support the
ubiquitination of IkBa (Figure 1, lanes 3 and 7). However, Fraction II was subjected to further purification as a
means of identifying the IkBa kinase and E3. Since phos-when fraction I was mixed with fraction II, multiubiquiti-
nation of IkBa was observed (Figure 1, lane 8). Fraction phorylation of IkBa at serine residues 32 and 36 is a
prerequisite for its ubiquitination (Chen et al., 1995), weI is known to contain a subfamily of E2s called Ubc4/
Ubc5, whereas fraction II contains all other known E2s first focused on identifying the kinase (characterization
of the E3 activity is in progress). To assay the kinase(Pickart and Rose, 1985). We therefore carried out ex-
periments to determine whether recombinant yeast activity, we took advantage of the observation that sig-
nal-induced phosphorylation of 35S-labeled IkBa leadsUbc4 can substitute for fraction I in catalyzing the ubi-
quitination of IkBa. Yeast Ubc4 alone catalyzed the for- to a reduction in its electrophoretic mobility on SDS±
polyacrylamide gels (Chen et al., 1995). Fraction II wasmation of low molecular mass ubiquitinated conjugates
of IkBa (Figure 1, lane 2). The E3-independent formation separated by Mono Q fast performance liquid chroma-
tography (FPLC) into five fractions using isocratic elutionof low molecular mass conjugates catalyzed by certain
E2s was previously reported (Pickart and Rose, 1985). with 0.1±0.5 M KCl. The IkBa kinase activity was de-
tected in the 0.3 M fraction (data not shown). ThisThe biological significance of this ubiquitination is not
clear, since these conjugates are not degraded by the fraction was concentrated by ammonium sulfate (40%)
precipitation, resuspended, and fractionated by size ex-26S proteasome (Hershko and Heller, 1985). Only protein
substrates conjugated to a multi-Ub chain are recog- clusion chromatography on Superdex-200 (Figure 2A).
The peak of the IkBa kinase activity eluted in fractionnized and degraded by the 26S proteasome (Chau et
al., 1989). When recombinant Ubc4 is added together 19, corresponding to an apparent molecular mass of
approximately 700 kDa. To rule out the possibility thatwith fraction II, multiubiquitination of IkBa is reconstitu-
ted (Figure 1, lane 4). As a control, a mock Escherichia the large size is due to aggregation, the kinase-con-
taining fractions were further fractionated on Mono Qcoli extract or recombinant Ubc3 (also called Cdc34)
Ubiquitination-Dependent IkBa Kinase
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Figure 2. A High Molecular Mass Kinase
Phosphorylates IkBa at S32 and S36
(A) Fractionation of IkBa kinase on Superdex-
200. Fractions containing IkBa kinase from
Mono Q chromatography were pooled and
precipitated with 40% ammonium sulfate.
The resuspended precipitate was loaded
onto a Superdex-200 gel filtration column,
and fractions were tested for their ability to
phosphorylate 35S-labeled IkBa (the genera-
tion of the slower migrating band, as indi-
cated by p-IkBa). Lane 1, IkBa control; lane
2, no kinase fraction; lane 3, kinase fractions
(pooled) from Mono Q chromatography (Q);
lane 4, 40% ammonium sulfate precipitate
(Qa); lanes 5±13, fractions 17±25. No kinase
activity was detected in fractions 26±36 (data
not shown). The numbers 670 and 440 above
the autoradiogram indicate approximate mo-
lecular masses. The band above p-IkBa is
monoubiquitinated IkBa due to the presence
of fraction I in the reaction.
(B) Rechromatography of IkBa kinase on
Superdex-200. IkBa kinase±containing frac-
tions from Superdex-200 (fractions 18±21 in
[A]) were reapplied to a Mono Q column and eluted with a linear gradient from 150 mM to 400 mM NaCl. The active fractions were rechromato-
graphed on a Superdex-200 column. Lane 1, no kinase fraction; lane 2, kinase fractions (fractions 18±20) from the first Superdex-200 column
(S1); lane 3, kinase fractions (fractions 24±26) from the second Mono Q column (Q2); lanes 4±10, fractions 17±23 from the second Superdex-
200 column.
(C) Phosphorylation of IkBa mutants. [35S]IkBa mutant proteins were synthesized by in vitro translation and then tested for their ability to be
phosphorylated by IkBa kinase. Lanes 1 and 2, wild-type IkBa; lanes 3 and 4, S32A/S36A mutant; lanes 5 and 6, S32E/S36E mutant; lanes 7
and 8, DN mutant. Odd-numbered lanes are control reaction without IkBa kinase; even-numbered lanes show incubation with the IkBa kinase.
Phosphorylated IkBa is indicated by an asterisk.
(D) Phosphatase treatment of phosphorylated IkBa. [35S]IkBa was phosphorylated with the IkBa kinase, immunoprecipitated with antisera
against the C-terminus of IkBa, and then incubated with (lanes 2, 4 and 6) or without (lanes 1, 3 and 5) phosphatase (CIP). The samples were
analyzed by 9% SDS±polyacrylamide gel electrophoresis (SDS±PAGE). Lanes 1 and 2, wild-type IkBa (no epitope tags); lanes 3 and 4, IkBa
tagged with the Flag epitope at the N-terminus; lanes 5 and 6, S32A/S36A (also with Flag epitope).
(E) Thrombin treatment of phosphorylated IkBa. The immunoprecipitates shown above in (D) were digested with thrombin, and the supernatants
containing the N-terminal fragments were analyzed on 16.5% Tris±tricine polyacrylamide gel. The assignment of lanes is the same as in (D).
with a linear gradient of 0.15±0.4 M NaCl, and the peak 32 and 36), and S32E/S36E (serine to glutamic acid sub-
stitutions at residues 32 and 36) (Brockman et al., 1995).activity was pooled and resized on Superdex-200.
As shown in Figure 2B, the peak of kinase activity As shown in Figure 2C, phosphorylation of wild-type
IkBa resulted in a reduction in the electrophoretic mobil-again eluted in fraction 19. Ovalbumin, which was in-
cluded as a carrier protein, eluted in a fraction corre- ity (lane 2). By contrast, incubation of the mutant IkBa
proteins with the kinase fraction did not lead to a changesponding to its expected molecular mass (43 kDa). Thus,
the apparent high molecular mass of the kinase is not in electrophoretic mobility (Figure 2C, lanes 4, 6, and 8).
The S32E/S36E mutant exhibited a decreased electro-due to the formation of nonspecific aggregates. When
the kinase-containing fraction was analyzed on a native phoretic mobility (due to the two negative charges),
which was unaffected by the kinase activity.polyacrylamide gel by silver staining, three predominant
high molecular mass bands were observed (data not Although the results shown in Figure 2C strongly sug-
gest that the kinase phosphorylates IkBa at serine resi-shown). Although the molecular masses of these com-
plexes cannot be accurately estimated on the native gel dues 32 and 36, there is a remote possibility that these
two serine residues function as an ªanchorº site for thesystem, the bands migrated with mobilities correspond-
ing to masses of approximately 700 kDa, consistent kinase and phosphorylation actually occurs elsewhere.
To rule out this possibility, we removed the N-terminalwith the size predicted by gel filtration. On SDS±
polyacrylamide gels, these large proteins were sepa- fragment of the phosphorylated IkBa with thrombin,
which cleaves after residue 62, and examined whetherrated into distinct multiple lower molecular mass spe-
cies (data not shown), suggesting that the kinase is a the N-terminal fragment was still phosphorylated (Fig-
ures 2D and 2E). In Figure 2D, wild-type IkBa (lanes 3multisubunit complex. We made use of the active Super-
dex-200 fractions to investigate thebiochemical require- and 4) and the S32A/S36A mutant (lanes 5 and 6) were
incubated with the kinase fraction and then analyzedments for the kinase activity.
A critical test of the specificity of the kinase activity before and after treatment with calf intestinal alkaline
phosphatase (CIP). Since both the wild-type and mutantis whether it phosphorylates serine residues 32 and 36
of IkBa. We therefore tested a panel of IkBa mutants proteins were tagged by a Flag epitope at their N-termini
(Brockman et al., 1995; Chen et al., 1995), we also testedincluding DN (N-terminal truncation at amino acid 72),
S32A/S36A (serine to alanine substitutions at residues wild-type IkBa that was not epitope tagged (lanes 1 and
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Figure 3. Phosphorylation of IkBa Requires
Ubc4/Ubc5
(A) Phosphorylation of IkBa requires fraction
I. 35S-labeled IkBa was phosphorylated by
IkBa kinase in reaction mixtures containing
(lanes 2 and 5) or lacking (lanes 1, 3, and 4)
fraction I (FrI). Lanes 1 and 2, IkBa mutant
S32A/S36A; lanes 3±5, wild-type IkBa. In
lanes 1 and 3, IkBa kinase was not added to
the reaction.
(B) Phosphorylation of IkBa requires Ubc4/
Ubc5. 35S-labeled IkBa was incubated with
IkBa kinase in a reaction mixture containing
purified recombinant Ubc4 (yeast, lane 3), pu-
rified GST±Ubc5 (human, lane 4), or no E2
(lane 2). In lane 1, no IkBa kinase was added
to the reaction.
(C) Only functional Ubc4/Ubc5 stimulates the
phosphorylation of IkBa. E2s purified from
rabbit reticulocytes were tested for their abil-
ity to stimulate the phosphorylation of IkBa.
These E2s include E2 of 14 kDa (E214K) (lane
2), E217K (lane 3), E220K (lane 4), E225K (lane 5),
and E235K (lane 6). Other E2s that were tested include purified recombinant human Ubc2 (lane 7), yeast Ubc4 (lane 8), and GST±Ubch5 (lane
9). In lanes 10 and 11, the active site mutants of human Ubc5 were tested. C85A, the active site cysteine (C85) of Ubc5 was substituted with
alanine. C85S, C85 of Ubc5 was changed to serine. No E2 was added in lane 1.
(D) Thioester assays of E2s. The E2s and E2 mutants shown in (C) were also tested for their ability to form thioesters with [125I]Ub in the
presence of E1. The bands corresponding to the thioesters were not detected if the samples were heated in the presence of b-mercaptoethanol
(data not shown).
2 in Figures 2D and 2E) to ensure that the Flag epitope from rabbit reticulocytes, including E2 of 14 kDa (E214K),
E217K, E220K, E225K, and E235K. Remarkably, none of thesewould not complicate the interpretation of the results.
Phosphatase treatment of the phosphorylated wild- E2s stimulated the kinase activity (Figure 3C, lanes 2±6).
Similarly, recombinant Ubch2 (Figure 3C, lane 7) or yeasttype IkBa converted the slower migrating form into the
faster migrating form (Figure 2D, lanes 1±4), and this Ubc3 (data not shown) also failed to stimulate the kinase
activity. All of these E2s form thioesters with [125I]Ub inconversion was blocked by phosphatase inhibitors (data
not shown).When the thrombin-cleaved N-terminal frag- the presence of E1 and ATP (Figure 3D). Therefore,
among all E2s tested thus far, Ubc4/Ubc5 has the uniquements from the wild-type protein were analyzed on a
16.5% Tris±tricine gel (Figure 2E), the N-terminal frag- ability to stimulate the IkBa kinase activity.
We next carried out experiments todetermine whetherments (approximately 8 kDa) were found to contain
phosphoryl groups that could be dephosphorylated with the catalytic activity of E2 proteins is required for their
ability to stimulate the IkBa kinase activity. Specifically,CIP (lanes 1±4). Phosphatase treatment did not alter the
electrophoretic mobility of either the intact protein or we substituted the active site cysteine residue of Ubch5
with alanine (C85A) or serine (C85S) and analyzed thethe N-terminal fragment of the S32A/S36A mutant (Fig-
ures 2D and 2E, lanes 5 and 6), indicating that this mutant effects of these substitutions on E2-dependent IkBa
phosphorylation. As expected, these two mutants werewas not phosphorylated at the N-terminus. Since the
only residues at the N-terminus of IkBa that can be defective in forming thioesters with [125I]Ub (Figure 3D,
lanes 10 and 11). Significantly, they also failed to stimu-phosphorylated are S32 and S36 (Haskill et al., 1991),
we conclude that phosphorylation of IkBa by the high late the phosphorylation of IkBa by the IkBa kinase
(Figure 3C, lanes 10 and 11). We also found that inactiva-molecular mass IkBa kinase occurs at S32 and S36.
tion of Ubc4 or Ubc5 by N-ethylmaleimide resulted in a
loss of IkBa kinase stimulatory activity (data not shown).Ubc4/Ubc5 Is Required for the
Phosphorylation of IkBa Finally,when C85A or C85S mutants of GST±Ubch5 were
added to the phosphorylation reaction in large excessThe IkBa phosphorylation assays were initially carried
out under the same conditions as the assays for the (mutant to wild type ratio of 20:1), the Ubc5-dependent
phosphorylation of IkBa was inhibited (data not shown).ubiquitination of IkBa (i.e., fraction I was always added
to the reaction). When fraction I was omitted from the These results show that the Ub-conjugating function of
Ubc4/Ubc5 is required for the phosphorylation of IkBareaction, we were surprised to find that phosphorylation
of IkBa was markedly reduced (Figure 3A, lanes 4 and by the IkBa kinase.
5). As expected, fraction I did not stimulate the phos-
phorylation of the IkBa mutant, S32A/S36A (Figure 3A,
lanes 1 and 2). The kinase-stimulatory activity of fraction Ub Is Required for the Phosphorylation of IkBa
The unusual requirement for a catalytically active E2 inI could be replaced by purified recombinant yeast Ubc4
or Ubch5 (glutathione S-transferase [GST]±Ubch5) (Fig- the IkBa kinase assay suggested that Ub, which was
present in our assay mixture, might also be required. Inure 3B). The specificity of this E2-stimulatory activity
was addressed by testing five other purified E2 proteins fact, we were unable to observe IkBa phosphorylation
Ubiquitination-Dependent IkBa Kinase
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Figure 5. Phosphorylation of IkBa Requires E1, but Does Not Re-
quire Okadaic Acid or Binding to RelA
(A) E1 requirement. 35S-labeled IkBa translated in a wheat germ
extract was allowed to associate with recombinant RelA and then
precipitated with anti-RelA antisera. The immune complex was used
Figure 4. Phosphorylation of IkBa Requires Ub as a substrate for phosphorylation by IkBa kinase. All reactions
contain Ub and GST±Ubch5. Lane 1, no E1; lane 2, E1 added; lane(A) Concentration-dependent stimulation of IkBa phosphorylation
3, wheat germ extract added.by Ub. 35S-labeled IkBa was incubated with IkBa kinase in the pres-
(B) Okadaic acid and RelA requirement. 35S-labeled IkBa was phos-ence of different concentrations of Ub, and the phosphorylation of
phorylated by IkBa kinase in a reaction mixture containing all neces-IkBa was analyzed on SDS±polyacrylamide gels.
sary components (see Experimental Procedures) except for the fol-(B) Inhibition of Ub-dependent phosphorylation of IkBa by MeUb.
lowing subtractions: lane 1, no kinase; lane 3, no RelA; lane 4, no[35S]IkBa was incubated with IkBa kinase in the presence of Ub
okadaic acid (OA).(lanes 2 and 3) or MeUb (lane 6). In lanes 4 and 5, Ub (2.4 mM or 60
mM) was preincubated with E1 (0.1 mM) and Ubc4 (1 mM) at 378C
for 3 min to form an E2±Ub thioester. This mixture was then added
to the phosphorylation reaction mixture containing 35S-labeled IkBa,
phosphorylation of IkBa is inhibited (Figure 4B, lane 4).IkBa kinase, and MeUb (40 mM). In lanes 7±8, the preincubation
This inhibition can be reversed by adding a large excessmixture contains MeUb (40 mM) instead of Ub. The E2±MeUb thioes-
ter mixture was then added to the phosphorylation reaction mixture of Ub during the thioester formation (Figure 4B, lane
containing 2.4 mM (lane 7) or 60 mM (lane 8) Ub. 5). However, if Ubc4 and MeUb form a thioester first,
followed by the addition of Ub, no phosphorylation of
IkBa is observed, even when Ub is in excess (Figure 4B,when Ub was not added to the reaction (Figure 4A, lane
lanes 7 and 8). Thus, multiubiquitination appears to be1). However, significant levels of IkBa phosphorylation
required for the kinase activity. Consistent with this pos-were observed in the presence of 1 mM Ub (Figure 4A,
sibility, the isopeptidase inhibitor Ub aldehyde enhanceslane 4), which is less than the physiological concentra-
the phosphorylation of IkBa in crude extracts (data nottion of Ub (10±20 mM; Haas and Bright, 1985). The con-
shown). However, this enhancement is not observedcentration dependence of the Ub requirement suggests
with the more purified kinase fractions, presumably ow-a highly cooperative behavior, consistent with thepossi-
ing to the removal of contaminating isopeptidases.bility that multi-Ub chain formation is necessary for IkBa
phosphorylation (see below).
A number of observations rule out the possibility that Additional Requirements for the
Phosphorylation of IkBathe kinase-stimulatory effect of Ub is due to a contami-
nant in the Ub preparation (Sigma). First, recombinant The Ubc4/Ubc5 and Ub requirement for the phosphory-
lation of IkBa prompted us to determine whether E1 isUb (both bovine and yeast) expressed in E. coli stimulate
the kinase activity (data not shown); second, when Ub also required for this activity. The IkBa used in these
experiments was translated in a wheat germ extract(Sigma) was further purified by Mono S FPLC, the ki-
nase-stimulatory activity copurified with Ub (data not that contains wheat E1 (data not shown). Thus, it was
necessary to isolate IkBa from the extract by immuno-shown); third, methylated Ub (MeUb) does not stimulate
the kinase activity, but instead competitively inhibits precipitation. IkBa was first allowed to associate with
recombinant RelA homodimer, and the complex wasthe Ub-dependent phosphorylation of IkBa (Figure 4B).
Previous studies have shown that MeUb can be acti- then precipitated with the antisera against RelA. The
immunoprecipitates were used directly as a substratevated by E1, transferred to E2, and then conjugated
to protein substrates. However, conjugates containing in the IkBa phosphorylation assay. As shown in Figure
5A, phosphorylation of IkBa required the addition of E1MeUb cannot be multiubiquitinated owing to the lack of
free lysine residues in MeUb (Hershko and Heller, 1985). or wheat germ extract. This experiment also showed
that no other component in the wheat germ extract wasWhen an E2±Ub thioester is first allowed to form be-
tween Ubc4 and a low concentration of Ub (2.4 mM) and required for the phosphorylation of IkBa.
In our previous studies we found that the phosphatasethen mixed with a large excess of MeUb (40 mM), the
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inhibitor okadaic acid was necessary to observe phos- kinase was removed from the conjugation reaction (Fig-
ure 6C, lanes 8 and 9). Furthermore, the formation ofphorylation and ubiquitination of IkBa in crude HeLa cell
cytoplasmic extracts (Chen et al., 1995). These extracts these conjugates was significantly reduced by the pres-
ence of excess MeUb (Figure 6C, lane 11). The completealso contained substantial amounts of Rel proteins.
Thus, it is possible that IkBa must be in a complex with inhibition of the kinase activity by MeUb observed in
the experiment in Figure 4B was likely the consequenceRel proteins in order to be phosphorylated accurately.
For these reasons, all phosphorylation assays described of allowing the E2 to form a thioester with a large excess
of MeUb prior to the addition of Ub. The addition ofabove contain okadaic acid and recombinant RelA ho-
modimers (see Experimental Procedures). Although we MeUb should have resulted in the formation of low mo-
lecular mass conjugates by terminating the elongationfound that the presence of okadaic acid was necessary
to observe IkBa kinase activity during the early stages of multi-Ub chains. However, these low molecular mass
conjugates may not be detectable because [125I]Ub wasof kinase purification, it was not required for the activity
of the partially purified IkBa kinase (Figure 5B, lane 4). only a small fraction of the total Ub in the reaction (the
ratio of labeled to unlabeled Ub was <1:10). Therefore,Thus, an okadaicacid±sensitive phosphatase must have
been removed during the purification of IkBa kinase. the probability that [125I]Ub is incorporated into a discrete
short Ub chain is very low. Taken together, these resultsWe also found RelA is not required for the in vitro phos-
phorylation of IkBa (Figure 5B, lane 3). This observation support the hypothesis that multiubiquitination of an
unknown factor (probably as part of the kinase complex)is consistent with a recent report that the Drosophila IkB
homolog Cactus undergoes signal-induced degradation is required for the activation of the IkBa kinase. Since
multiubiquitinationof protein substrates usually requires(and presumably also phosphorylation) in Drosophila
embryos lacking the Rel family protein Dorsal (Belvin et an E3, the IkBa kinase complex probably contains an
E3 activity. The identity of this E3 and the target ofal., 1995).
ubiquitination remains to be determined.
A Ubiquitination Event Activates IkBa Kinase
Why does phosphorylation of IkBa by the IkBa kinase
Discussionrequire E1, Ubc4, or Ubc5 and Ub? One possibility is
that ubiquitination of an as yet unidentified factor is
Degradation of a number of proteins has been shownnecessary for the activation of IkBa kinase. This possi-
to be induced by phosphorylation (Lin and Desiderio,bility is consistent with the time course of IkBa phos-
1993; Yaglom et al., 1995) and dephosphorylation (Nishi-phorylation, which is biphasic: a lag of 6 min followed
zawa et al., 1993), and in some cases the Ub±by a burst of IkBa phosphorylation (Figure 6A, lanes
proteasome pathway has been implicated. The inactiva-1±5, and Figure 6B). This kinetic behavior suggests that
tion of IkBa is a well-characterized example of couplingan additional event precedes kinase activation. To test
between phosphorylation and ubiquitination (Chen etthis possibility, we preincubated the partially purified
al., 1995; Scherer et al., 1995; Alkalay et al., 1995b). WeIkBa kinase with E1, Ubc4, and Ub in the presence of
have previously shown that ubiquitination of IkBa isATP at 378C for 10 min and then initiated the phosphory-
regulated by its phosphorylation at S32 and S36 (Chenlation reaction by the addition of 35S-labeled IkBa (Figure
et al., 1995), residues required for the signal-induced6A, lanes 10±13, and Figure 6B). Remarkably, the prein-
phosphorylation and degradation of IkBa in vivo (Browncubation eliminated the lag phase of IkBa phosphoryla-
et al., 1995; Brockman et al., 1995; Traenckner et al.,tion. When the IkBa kinase was not added to the prein-
1995; Whiteside et al., 1995). Here we showthat a ubiqui-cubation mixture (Figure 6B), or when Ub was omitted
tination event is required for the activation of an IkBafrom the preincubation mixture (Figure 6A, lanes 6±9,
kinase, which phosphorylates IkBa at S32 and S36. Thisand Figure 6B), the lag phase of IkBa phosphorylation
two-step ubiquitination pathway for IkBa degradationpersisted. The extent of IkBa phosphorylation was re-
is illustrated in Figure 7. The ubiquitination of the IkBaduced slightly when IkBa kinase was included in the
kinase does not require an exogenous E3, suggestingpreincubation mixture (compare lanes 5, 9, and 13 in
that the IkBa kinase complex possesses an E3 activityFigure 6A). This is probably due to the instability of IkBa
(shown as E3x in Figure 7). The activated kinase thenkinase when incubated at 378C for an additional 10 min.
phosphorylates IkBa, leading to the site-specific ubiqui-These results strongly suggest that the IkBa kinase was
tination of the inhibitor at K21 and K22 (Scherer et al.,activated during the preincubation period, most likely
1995). Neither phosphorylation (reviewed by Finco andby a ubiquitination event.
Baldwin, 1995) nor ubiquitination (Chen et al., 1995) re-To demonstrate directly that ubiquitination occurs
sults in the dissociation of the IkBa±NF-kB complex.during the preincubation reaction, we incubated E1,
Ubiquitinated IkBa on the complex is degraded by theUbc4, and IkBa kinase with [125I]Ub in the presence of
26S proteasome (Chen et al., 1995). The E3 required forATP. As shown in Figure 6C, a time-dependent accumu-
the second ubiquitination event (E3y in Figure 7) maylation of high molecular mass ubiquitinated conjugates
be distinct from E3x, since the partially purified kinasewas observed (these conjugates were unable to enter
is not capable of ubiquitinating IkBa in the presence ofthe 5% stacking gel). The kinetics of conjugate accumu-
E1, Ubc4/Ubc5, and Ub (data not shown). By contrast,lation paralleled that of IkBa phosphorylation only when
the same E2, Ubc4/Ubc5, is required for both the phos-IkBa kinase was preincubated with E1, Ubc4, and Ub
phorylation and ubiquitination of IkBa.(compare Figures 6B and 6D). This observation is con-
Another example of the coupling of phosphorylationsistent with the idea that formation of these conjugates
and ubiquitination is provided by the ubiquitination ofprecedes the phosphorylation of IkBa. Conjugate forma-
tion was not observed when either Ubc4 or the IkBa mitotic cyclins by the cyclosome, a 20S complex that
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Figure 6. IkBa Kinase Is Activated by a Prior Ubiquitination Event
(A) Preincubation of IkBa kinase with ubiquitination enzymes and Ub eliminates the lag phase in the phosphorylation of IkBa. 35S-labeled IkBa
was incubated with IkBa kinase in the presence of E1, Ubc4, and Ub. After 0, 3, 6, 10, and 20 min at 378C, an aliquot of the reaction was
analyzed by SDS±PAGE (lanes 1±5). In lanes 10±13, IkBa kinase was preincubated with E1, Ub, and Ubc4 in the presence of ATP at 378C for
10 min before the addition of 35S-labeled IkBa, which initiated the phosphorylation reaction. In lanes 6±9, Ub was omitted from the preincubation
mixture, but added together with 35S-labeled IkBa. The doublets above IkBa probably represent phosphorylation at one or both serine residues
at positions 32 and 36.
(B) Kinetics of IkBa phosphorylation. Phosphorylated IkBa (p-IkBa) shown in (A) was quantitated by phosphorimager analysis and expressed
as the percentage of IkBa converted to p-IkBa. Open circle, no preincubation; closed circle, preincubation in the presence of IkBa kinase
and Ub; open triangle, preincubation in the absence of IkBa kinase; closed triangle, preincubation in the absence of Ub; open square, no
ubiquitination enzymes or Ub in the reaction.
(C) Formation of high molecular mass Ub conjugates in the presence of Ubc4 and IkBa kinase. IkBa kinase was incubated with E1, Ubc4,
and [125I]Ub in the presence of an ATP regenerating system. After 0, 3, 6, 10, 20, and 40 min at 378C (lanes 1±6), the reaction was quenched
and analyzed by SDS±PAGE (5% stacking gel, 9% separating gel). In lanes 7±11, the ubiquitination reactions were carried out for 45 min in
the presence or absence of Ubc4 or IkBa kinase, as shown in the figure. In lane 11, MeUb (0.15 mM) was added to the reaction. In lanes 2,
3, and 4, free Ub ran off the gel. NS, nonspecific bands.
(D) Kinetics of IkBa kinase ubiquitination. The high molecular mass conjugates on the top of the gel shown in (C) (lanes 1±6) were quantitated
by phosphorimager analysis and expressed as a function of time.
harbors an E3 activity (E3-C; Sudakin et al., 1995; King The kinase activity described here has several proper-
ties expected for a bona fide IkBa kinase. It phosphory-et al., 1995). The activity of E3-C is dependent on Cdc2,
a cyclin-dependent kinase. The activation of E3-C by lates both free IkBa and IkBa bound to RelA at serine
residues 32 and 36. In addition, IkBa phosphorylatedCdc2 is indirect, however, since pretreatment of cyclo-
some with Cdc2 abolishes a lag phase in the ubiquitina- by this kinase remains bound to NF-kB (data not shown),
a property expected from in vivo studies (reviewed bytion of cyclins. Therefore, a phosphorylation cascade
may be propagated from Cdc2 within the cyclosome. Finco and Baldwin, 1995). This property of the kinase
Figure 7. A Two-Step Ubiquitination Path-
way for IkBa Degradation
Ubiquitination is required for both the activa-
tion of the IkBa kinase complex and the deg-
radation of IkBa. A specific E2, Ubc4/Ubc5,
mediatesboth ubiquitination steps. However,
the E3 required for the ubiquitination of IkBa
kinase (E3x) may be distinct from that re-
quired for the ubiquitination of IkBa (E3y). The
phosphorylated (indicated by bold P)and ubi-
quitinated IkBa (indicated by the branched
structure) remains associated with NF-kB.
Following ubiquitination, IkBa is degraded by
the 26S proteasome.
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is in contrast with previous examples of in vitro IkBa acid is not required to activate the kinase activity in our
phosphorylation, which resulted in the dissociation of most purified fractions (Figure 5B). In addition, the IkBa
the NF-kB±IkBa complex (Ghosh and Baltimore, 1990; kinase was purified from unstimulated HeLa cell ex-
Kumar et al., 1994). Finally, the in vitro phosphorylated tracts. However, HeLa cells may have a relatively high
IkBa can be ubiquitinated at specific lysine residues level of constitutive kinase activity compared with nor-
(K21 and K22) (Chen et al., 1995; Scherer et al., 1995), mal (untransformed) cells. NF-kB can be activated by
and these residues are required for signal-induced deg- okadaic acid alone in transformed cells, whereas an
radation of IkBa in vivo (Scherer et al., 1995). additional signal such as H2O2 is required to activate
The determination of the role of this kinase in vivo will NF-kB in primary cells (Menon et al., 1993). It is also
require the identification and inactivation of the gene(s) possible that the state of phosphorylation of IkBa in
encoding the kinase complex. It is interesting in this vivo is determined by a balance between kinase and
regard that heat inactivation of a mutant E1 protein re- phosphatase activities, and a small up-regulation of the
sults in the accumulation of unphosphorylated IkBa in kinase would be sufficient to target IkBa to the degrada-
cells stimulated by interleukin-1 (Alkalay et al., 1995b). tion pathway. It may not be possible to mimic these
By contrast, stimulated cells treated with proteasome conditions in vitro, where ubiquitination enzymes and
inhibitors accumulate both phosphorylated and unphos- Ub are in large excess.
phorylated IkBa. These observations areconsistent with Most, if not all, of the known NF-kB inducers result
the possibility that E1 is required for both the phosphory- in oxidative stress through the generation of reactive
lation and degradation of IkBa in vivo (Figure 7). oxygen intermediates (ROIs; Schreck et al., 1991). ROIs
Ubiquitination, not Ub-dependent degradation, acti- could affect the phosphorylation of IkBa directly by acti-
vates the kinase, since proteolytic activity isnot required vating an IkBa kinase(s) or by inactivating an IkBa phos-
for IkBa phosphorylation in the partially purified system phatase(s). Alternatively, the effect of ROIs on IkBa
(data not shown). Furthermore, proteasome inhibitors phosphorylation may be indirect. For example, ROIs
do not inhibit the phosphorylation of IkBa in vivo (Palom- might trigger a stress response, which would in turn lead
bella et al., 1994; Traenckner et al., 1994; Brockman et to the phosphorylation of IkBa. A possible connection
al., 1995; Chen et al., 1995) or in vitro (Scherer et al., between ROIs and the Ub±proteasome pathway is pro-
1995; data not shown). In addition, the activation of the vided by certain proteins (e.g., RNase A) in which mild
IkBa kinase in vitro correlates with the accumulation
oxidation of methionine residues greatly increases their
of multiubiquitinated conjugates that are not degraded
susceptibility to ubiquitination (Hershko et al., 1986).
(Figure 6). Finally, in contrast with MeUb, in which all
IkBa not only is phosphorylated in response to a vari-
seven lysine residues are blocked by methylation, a Ub
ety of extracellular signals; a basal level of phosphoryla-
mutant (K48R) that cannot form multi-Ub chains through
tion is also observed (reviewed by Verma et al., 1995).
K48 is still capable of stimulating the IkBa kinase activity
The basal phosphorylation sites have been mapped to(data not shown). K48-linked multi-Ub chains are
the C-terminal casein kinase II sites in the PEST regionthought to be specifically recognized by the 26S protea-
of IkBa, and S293 is thepreferred site of phosphorylationsome (Chau et al., 1989). However, multi-Ub chains with
(Barroga et al., 1995; Kuno et al., 1995). Deletion of alinkages through lysine residues other than K48 also
C-terminal region of IkBa that includes the PEST se-exist in cells, and they play important roles in stress
quence or mutation of the basal phosphorylation sitesresponse (Arnason and Ellison, 1994) and DNA repair
does not prevent the inducible phosphorylation of IkBa(Spence et al., 1995). It is possible that different multi-Ub
(Brown et al., 1995; Brockman et al., 1995; Traencknerchain configurations may be involved in the regulation of
et al., 1995; Whiteside et al., 1995; Verma et al., 1995).protein activity, rather than proteolysis (Arnason and
Consistent with this result, we find that deletion of theEllison, 1994).
C-terminal 75 amino acids of IkBa does not prevent theAlthough we have shown that a component of the
kinase described here from phosphorylating this mutantpartially purified kinase is ubiquitinated in vitro, and that
(data not shown).this event is required for the kinase activity, we have
NF-kB isan attractive target for drugdesign and thera-not identified the target of ubiquitination. This target
peutic intervention because of its involvement in manycould be the kinase or an essential component of the
pathological conditions, such as inflammation, autoim-kinase complex. This covalent modification of the IkBa
mune disease, cancer, and viral infection. A number ofkinase complex could activate the kinase by inducing
studies have shown that the inhibition of NF-kB activitya conformational change, or ubiquitination could inacti-
could have profound physiological effects (reviewed byvate a kinase inhibitor. Several cyclin-dependent kinase
Verma et al., 1995). Recent studies of the mechanisminhibitors, such as p40SIC1 (Schwob et al., 1994) and p27
of NF-kB activation have provided new targets for drug(Pagano et al., 1995), have been shown to be targets of
intervention. The identification of a novel IkBa kinasethe Ub±proteasome pathway. However, none of these
and the ubiquitination enzymes required for its activa-appears to be inactivated by ubiquitination alone.
We have shown that a ubiquitination event is required tion provides new opportunities for inhibiting aberrant
for the activation of the IkBa kinase in vitro, but we have NF-kB functions.
not determined whether this event is regulated in vivo.
It is possible that the kinase activity is constitutive in vivo Experimental Procedures
and IkBa phosphorylation is controlled by inactivation
of a phosphatase. Alternatively, the kinase activity is Plasmids, Proteins, and Antibodies
regulated by signals that induce NF-kB. The former pos- cDNAs encoding IkBa and its mutants have been described pre-
viously (Brockman et al., 1995; Chen et al., 1995). 35S-labeled IkBasibility is consistent with the observation that okadaic
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(Promega). pGEX-2TK-Ubch5 was constructed by PCR using Ubch5 and O. Coux for recombinant Ubc2 protein. We are grateful to C.
cDNA (provided by Dr. P. Howley) as a template. The active site Pickart for helpful discussions. We also thank J. Adams, R. Stein,
mutants of Ubch5, pGEX-2TK-Ubch5 (C85A) and pGEX-2TK- V. Palombella, D. Ballard, and A. L. Goldberg for critical reading of
Ubch5(C85S), were created by site-directed mutagenesis using the the manuscript. We are indebted to R. Stein, J. Adams, and other
Unique Site Elimination mutagenesis kit (Pharmacia). All constructs scientists at ProScript, Incorporated for their support of this work.
were confirmed by DNA sequencing. For expression of GST±Ubch5
and its mutants, the appropriate expression constructs were trans- Received January 9, 1996; revised January 30, 1996.
formed into the E. coli strain BL21/DE3, and protein expression was
induced with 200 mM IPTG. GST fusion proteins were purified using References
glutathione±Sepharose. Yeast Ubc4 was expressed in the E. coli
AR58 harboring the Ubc4 expression vector (pLlUbc4; provided by Alkalay, I., Yaron, A., Hatzubai, A., Jung, S., Avraham, A., Gerlitz,
Dr. V. Chau). After heat induction (308C to 428C), Ubc4 was purified O., Pashut-Lavon, I., and Ben-Neriah, Y. (1995a). In vivo stimulation
by Ub±Sepharose covalent chromatography, followed by gel filtra- of IkB phosphorylation is not sufficient to activate NF-kB. Mol. Cell.
tion on Superdex-200. Recombinant RelA homodimer and Ubch2 Biol. 15, 1294±1301.
were provided by Drs. J. Hagler and O. Coux, respectively. Purifica- Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A., and
tion of E1, E2 of 14 kDa (E214K), E217K, E220K, E225K, aand E235K from Ben-Neriah, Y. (1995b). Stimulation-dependent IkBa phosphoryla-
rabbit reticulocytes was performed according to Haas and Bright
tion marks the NF-kB inhibitor for degradation via the ubiquitin-(1988). Preparation of MeUb and Ub aldehyde have been described
proteasome pathway. Proc. Natl. Acad. Sci. USA 92, 10599±10603.previously (Chen et al., 1995). [125I]Ub was prepared by the chlora-
Arnason, T., and Ellison, M.J. (1994). Stress resistance in Saccharo-mine T method. Antibodies against IkBa and RelA were obtained
myces cerevisiae is strongly correlated with assembly of a novelfrom Santa Cruz Biotechnology.
type of multiubiquitin chain. Mol. Cell. Biol. 14, 7876±7883.
Fractionation of HeLa Cell Cytoplasmic Extracts Barroga, C.F., Stevenson, J.K., Schwarz, E.M., and Verma, I.M.
and Purification of IkBa Kinase (1995). Constitutive phosphorylation of IkBa by casein kinase II.
Preparation of okadaic acid±inducible HeLa cell cytoplasmic ex- Proc. Natl. Acad. Sci. USA 92, 7637±7641.
tracts has been described previously (Chen et al., 1995). The extracts Belvin, M.P., Jin, Y., and Anderson, K.V. (1995). Cactus protein deg-
were applied to Mono Q equilibrated in buffer A (50 mM Tris±HCl radation mediates Drosophila dorsal-ventral signaling. Genes Dev.
[pH 7.5], 0.5 mM DTT), and the flowthrough was collected and con- 9, 783±793.
centrated (fraction I). To prepare fraction II, bound proteins were
Brockman, J.A., Scherer, D.C., Hall, S.M., McKinsey, T.A., Qi, X.,eluted with buffer B (buffer A plus 0.5 M KCl) and concentrated. To
Lee, W.Y., and Ballard, D.W. (1995). Coupling of a signal-responsepurify IkBa kinase, proteins bound to Mono Q were eluted stepwise
domain in IkBa to multiple pathways for NF-kB activation. Mol. Cell.with 0.1, 0.2, 0.3, 0.4, and 0.5 M KCl in buffer A. The IkBa kinase
Biol. 15, 2809±2818.containing fractions (0.2±0.3 M KCl eluate) were pooled and further
fractionated by ammonium sulfate (40%) precipitation. The resus- Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist,
pended precipitates were then separated by size exclusion chroma- U. (1995). Control of IkB-a proteolysis by site-specific, signal-
tography on Superdex 200 in buffer C (50 mM Tris±HCl [pH 7.5], 0.5 induced phosphorylation. Science 267, 1485±1491.
mM DTT, 150 mM NaCl). The active fractions were applied to Mono Chau, V.,Tobias, J.W., Bachmair, A., Marriott, D., Ecker, D.J.,Gonda,
Q and then eluted with a linear gradient of 0.15±0.4 M NaCl in buffer D.K., and Varshavsky, A. (1989). A multiubiquitin chain is confined
C. The fractions containing IkBa kinase were resized on Superdex- to specific lysine in a targeted short-lived protein. Science 243,
200 as described above. Active fractions were pooled, concen- 1576±1583.
trated, and stored at 2808C.
Chen, P., Johnson, P., Sommer, T., Jentsch, S., and Hochstrasser,
M. (1993). Multiple ubiquitin-conjugating enzymes participate in thePhosphorylation and Ubiquitination Assays
in vivo degradation of the yeast MATa2 repressor. Cell 74, 357±369.Unless otherwise indicated, phosphorylation of IkBa was usually
carried out at 378C for 1 hr in a reaction volume of 10 ml containing Chen, Z.J., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D.,
the following: an ATP regenerating system (Chen et al., 1995), 0.5 Ballard, D., and Maniatis, T. (1995). Signal-induced site-specific
ml of in vitro translated 35S-labeled IkBa, 2 mg/ml recombinant RelA phosphorylation targets IkBa to the ubiquitin-proteasome pathway.
homodimer (to form complex with IkBa), 3 mM okadaic acid, 60 mM Genes Dev. 9, 1586±1597.
Ub, 50 nM E1 (rabbit), 1 mM Ubc4 (yeast), or GST±Ubch5 (human), Ciechanover, A. (1994). The ubiquitin±proteasome proteolytic path-
and 0.5±3 ml of IkBa kinase±containing fractions. In some experi- way. Cell 79, 13±21.
ments, HeLa fraction I (1 mg/ml) was used as a source of E2s.
DiDonato, J.A., Mercurio, F., and Karin, M. (1995). PhosphorylationThe reaction products were analyzed by SDS±polyacrylamide gel
of IkB precedes but is not sufficient for its dissociation from NF-electrophoresis (SDS±PAGE) (9%) followed by fluorography. Phos-
kB. Mol. Cell. Biol. 15, 1302±1311.phorylation of IkBa was quantitated by phosphorimager analysis.
Ubiquitination of IkBa has been described previously (Chen et al., Finco, T.S., and Baldwin, A.S., Jr. (1995). Mechanistic aspects of NF-
1995). Thioester assays were carried out as described by Haas and kB regulation: the emerging role of phosphorylation and proteolysis.
Bright (1988). Immunity 3, 263±272.
Finco, T.S., Beg, A.A., and Baldwin, A.S., Jr. (1994). Inducible phos-
Phosphatase and Thrombin Treatment phorylation of IkBa is not sufficient for its dissociation from NF-kB
Following phosphorylation of IkBa (see above), IkBa was immuno- and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA
precipitated with anti-IkBa antisera (against the C-terminus of IkBa) 91, 11884±11888.
as described before (Chen et al., 1995). In dephosphorylation reac-
Ghosh, S., and Baltimore, D. (1990). Activation in vitro of NF-kB bytions, CIP (1.8 U/ml) was added to the beads containing the IkBa
phosphorylation of its inhibitor IkB. Nature 344, 678±682.immune complexand incubated at 378Cfor 30 min. Control reactions
contain either dephosphorylation buffer (50 mM Tris-HCl [pH 8.5], Goldberg, A.L. (1995). Functions of the proteasome: the lysis at the
1 mM EDTA) alone or CIP plus a phosphatase inhibitor cocktail end of the tunnel. Science 268, 522±523.
(Chen et al., 1995). Thrombin treatment and Tris±tricine gel analysis Haas, A.L., and Bright, P.M. (1985). The immunochemical detection
were performed according to Whiteside et al. (1995), except the and quantitation of intracellular ubiquitin-protein conjugates. J. Biol.
reactions were carried out at 308C for 2 hr. Chem. 250, 12464±12473.
Haas, A.L., and Bright, P.M. (1988). The resolution and characteriza-Acknowledgments
tion of putative ubiquitin carrier protein isozymes from rabbit reticu-
locytes. J. Biol. Chem. 263, 13258±13267.Correspondence should be addressedto Z. J. C. We thank D. Ballard
for the IkBa mutant cDNAs, P. Howley for the Ubch5 cDNA, V. Chau Haskill, S., Beg, A.A., Tompkins, S.N., Morris, J.S., Yurochko, A.D.,
Cell
862
Sampson-Johannes, A., Mondal, K., Ralph, P., and Baldwin, A.S., intermediates as apparently widely used messengers in the activa-
tion of the NF-kB transcription factor and HIV-1. EMBO J. 10, 2247±Jr. (1991). Characterization of an immediate-early gene induced in
adherent monocytes that encodes IkB-like activities. Cell 65, 1281± 2258.
1289. Schwob, E., BoÈ hm, T., Mendenhall, M.D., and Nasmyth, K. (1994).
The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transi-Hershko, A., and Heller, H. (1985). Occurrence of a polyubiquitin
tion in S. cerevisiae. Cell 79, 233±244.structure in ubiquitin-protein conjugates. Biochem. Biophys. Res.
Commun. 128, 1079±1086. Seufert, W., and Jentsch, S. (1990). Ubiquitin-conjugating enzymes
UBC4 and UBC5 mediate selective degradation of short-lived andHershko, A., Heller, H., Eytan, E., and Reiss, Y. (1986). The protein
abnormal proteins. EMBO J. 9, 543±550.substrate binding site of the ubiquitin-protein ligase system. J. Biol.
Siebenlist, U., Franzoso, G., and Brown, K. (1994). Structure, regula-Chem. 261, 11992±11999.
tion and function of NF-kB. Annu. Rev. Cell Biol. 10, 405±455.Huibregtse, J.M., Scheffner, M., Beaudenon, S., and Howley, P.
Spence, J., Sadis, S., Haas, A.L., and Finley, D. (1995). A ubiquitin(1995). A family of proteins structurally and functionally related to
mutant with specific defects in DNA repair and multiubiquitination.the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92,
Mol. Cell. Biol. 15, 1265±1273.2563±2567.
Sudakin, V., Ganoth, D., Dahan, A., Heller, H., Hershko, J., Luca,King, R.W., Peters, J.-M., Tugendreich, S., Rolfe, M., Hieter, P.,
F.C., Ruderman, J.V., and Hershko, A. (1995). The cyclosome, aand Kirschner, M.W. (1995). A 20S complex containing CDC27 and
large complex containing cyclin-selective ubiquitin ligase activity,CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to
targets cyclins for destruction at the end of mitosis. Mol. Biol. Cellcyclin B. Cell 81, 279±288.
6, 185±198.
Kumar, A., Haque, J., Lacoste, J., Hiscott, J., and Williams, B. (1994).
Thanos, D., and Maniatis, T. (1995). NF-kB: a lesson in family values.Double-stranded RNA-dependent protein kinase activates tran-
Cell 80, 529±532.scription factor NF-kB by phosphorylating IkB. Proc. Natl. Acad.
Traenckner, E.B.-M., Wilk, S., and Baeuerle, P.A. (1994). A protea-Sci. USA 91, 6288±6292.
some inhibitor prevents activation of NF-kB and stabilizes a newly
Kuno, K., Ishikawa, Y., Ernst, M.K., Ogata, M., Rice, N.R., Mukaida,
phosphorylated form of IkB-a that is still bound to NF-kB. EMBO
N., and Matsushima, K. (1995). Identification of an IkBa-associated
J. 13, 5433±5441.
protein kinase in a human monocytic cell line and determination of
Traenckner, E.B.-M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S.,its phosphorylation sites on IkBa. J. Biol. Chem. 270, 27914±27919.
andBaeuerle, P.A. (1995). Phosphorylation of human IkBa onserines
Lin, W.-C., and Desiderio, S. (1993). Regulation of V(D)J recombina- 32 and 36 controls IkBa proteolysis and NF-kB activation in re-
tion activator protein RAG-2 by phosphorylation. Science 260, sponse to diverse stimuli. EMBO J. 14, 2876±2883.
953±959.
Verma, I.M., Stevenson, J.K., Schwarz, E.M., Van Antwerp, D., and
Lin, Y.-C., Brown, K., and Siebenlist, U. (1995). Activation of NF-kB Miyamoto, S. (1995). Rel/NF-kB/IkB family: intimate tales of associa-
requires proteolysis of the inhibitor IkB-a: signal-induced phosphor- tion and dissociation. Genes Dev. 9, 2723±2735.
ylation of IkB-a alone does not release active NF-kB. Proc. Natl. Whiteside, S.T., Ernst, M.K., LeBail, O., Laurent-Winter, C., Rice, N.,
Acad. Sci. USA 92, 552±556. and Israel, A. (1995). N- and C-terminal sequences control degrada-
Menon, S.D., Qin, S., Guy, G.R., and Tan, Y.H. (1993). Differential tion of MAD3/IkBa in response to inducers of NF-kB activity. Mol.
induction of nuclear NF-kB by protein phosphatase inhibitors in Cell. Biol. 15, 5339±5345.
primary and transformed human cells. J. Biol. Chem. 268, 26805± Yaglom, J., Linskens, M.H., Sadis, S., Rubin, D.M., Futcher, B., and
26812. Finley, D. (1995). p34cdc28-mediated control of Cln3 cyclin degrada-
tion. Mol. Cell. Biol. 15, 731±741.Miyamoto, S., Maki, M., Schmitt, M.J., Hatanaka, M., and Verma,
I.M. (1994). Tumor necrosis factor a-induced phosphorylation of
IkBa is a signal for its degradation but not dissociation from NF-
kB. Proc. Natl. Acad. Sci. USA 91, 12740±12744.
Nishizawa, M., Furuno, N., Okazaki, K., Tanaka, H., Ogawa, Y., and
Sagata, N. (1993). Degradation of Mos by the N-terminal proline
(Pro2)-dependent ubiquitin pathway on fertilization of Xenopus eggs:
possible significance of natural selection for Pro2 in Mos. EMBO J.
12, 4021±4027.
Orian, A., Whiteside, S., Israel, A., Stancovski, I., Schwartz, A.L., and
Ciechanover, A. (1995). Ubiquitin-mediated processing of NF-kB
transcriptional activator precursor p105. J. Biol. Chem. 270, 21707±
21714.
Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal,
G., Chau, V., Renee Yew, P., Draetta, G.F., and Rolfe, M. (1995).
Role of the ubiquitin-proteasome pathway in regulating abundance
of the cyclin-dependent kinase inhibitor p27. Science 269, 682±685.
Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.
(1994). The ubiquitin±proteasome pathway is required for pro-
cessing the NF-kB1 precursor protein and the activation of NF-kB.
Cell 78, 773±785.
Pickart, C.M., and Rose, I.A. (1985). Functional heterogeneity of
ubiquitin carrier proteins. J. Biol. Chem. 260, 1573±1581.
Scheffner, M., Huibregtse, J.M., Vierstra, R.D., and Howley, P.M.
(1993). The HPV-16 E6 and E6-AP complex functions as a ubiquitin±
protein ligase in the ubiquitination of p53. Cell 75, 495±505.
Scherer, D.C., Brockman, J.A., Chen, Z.J., Maniatis, T., and Ballard,
D. (1995). Signal-induced degradation of IkBa requires site-specific
ubiquitination. Proc. Natl. Acad. Sci. USA 92, 11259±11263.
Schreck, R., Rieber, P., and Baeuerle, P.A. (1991). Reactive oxygen
